We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+22.33%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$385B
AUM Growth
+$32.1B
Cap. Flow
-$35.1B
Cap. Flow %
-9.14%
Top 10 Hldgs %
30.5%
Holding
11,975
New
1,989
Increased
4,461
Reduced
4,218
Closed
1,130

Sector Composition

Rank Sector Weight
1 Technology 3.66%
2 Healthcare 3.16%
3 Industrials 2.01%
4 Financials 1.98%
5 Consumer Discretionary 1.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PBYI icon
8851
PUT
Puma Biotechnology
PBYI
$454M
$316K ﹤0.01%
30,800
-2,200
-7% -$22.3K
PRGS icon
8852
PUT
Progress Software
PRGS
$1.76B
$316K ﹤0.01%
7,000
-27,900
-80% -$1.13M
TA
8853
PUT
DELISTED
TravelCenters of America LLC
TA
$316K ﹤0.01%
9,700
-27,500
-74% -$811K
IWR icon
8854
PUT
iShares Russell Mid-Cap ETF
IWR
$57.4B
$315K ﹤0.01%
4,600
-600
-12% -$38.2K
PRLB icon
8855
Protolabs
PRLB
$2.13B
$315K ﹤0.01%
2,050
-8,990
-81% -$1.27M
AIXC
8856
PUT
AIxCrypto Holdings Inc
AIXC
$16.6M
$315K ﹤0.01%
+210
New +$411K
REX icon
8857
REX American Resources
REX
$1.41B
$315K ﹤0.01%
25,716
-5,328
-17% -$70K
RING icon
8858
iShares MSCI Global Gold Miners ETF
RING
$2.56B
$315K ﹤0.01%
10,528
-25,562
-71% -$791K
SDIV icon
8859
PUT
Global X SuperDividend ETF
SDIV
$1.21B
$315K ﹤0.01%
8,167
+2,867
+54% +$102K
ROUS icon
8860
Hartford Multifactor US Equity ETF
ROUS
$717M
$314K ﹤0.01%
+8,935
New +$300K
VRAY
8861
CALL
DELISTED
ViewRay, Inc.
VRAY
$314K ﹤0.01%
82,300
+3,400
+4% +$12K
ATHX
8862
PUT
DELISTED
Athersys, Inc. Common Stock
ATHX
$314K ﹤0.01%
7,172
+1,120
+19% +$50.9K
RBIN
8863
DELISTED
Nationwide Risk-Based International Equity ETF
RBIN
$314K ﹤0.01%
11,582
-50
-0.4% -$1.3K
ZJPN
8864
DELISTED
SPDR Solactive Japan ETF
ZJPN
$314K ﹤0.01%
3,551
-291
-8% -$24K
FXP icon
8865
CALL
ProShares UltraShort FTSE China 50 of ProShares Trust
FXP
$5.75M
$313K ﹤0.01%
+4,800
New +$340K
MCY icon
8866
PUT
Mercury Insurance
MCY
$6.07B
$313K ﹤0.01%
6,000
-7,200
-55% -$322K
MMSI icon
8867
Merit Medical Systems
MMSI
$5.32B
$313K ﹤0.01%
+5,632
New +$291K
NRGU icon
8868
MicroSectors U.S. Big Oil 3x Leveraged ETNs due Feb 17 2045
NRGU
$19.2M
$313K ﹤0.01%
5,119
+3,983
+351% +$184K
TEGS
8869
DELISTED
Trend Aggregation ESG ETF
TEGS
$313K ﹤0.01%
11,848
+4,004
+51% +$113K
AVDL
8870
PUT
DELISTED
Avadel Pharmaceuticals
AVDL
$312K ﹤0.01%
46,700
-2,400
-5% -$15K
AX icon
8871
PUT
Axos Financial
AX
$5.68B
$312K ﹤0.01%
8,300
-8,200
-50% -$259K
KBR icon
8872
PUT
KBR
KBR
$4.8B
$312K ﹤0.01%
+10,100
New +$266K
IMDX
8873
CALL
Insight Molecular Diagnostics
IMDX
$156M
$312K ﹤0.01%
6,525
+5,815
+819% +$213K
AIOT
8874
CALL
PowerFleet Inc
AIOT
$592M
$312K ﹤0.01%
42,000
+5,800
+16% +$38.8K
RFP
8875
CALL
DELISTED
Resolute Forest Products Inc.
RFP
$312K ﹤0.01%
47,700
+28,400
+147% +$155K

Similar funds

Citadel Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, Citadel Advisors held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Citadel Advisors withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.7% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Citadel Advisors opened a new position in S&P Global worth $114M.

  • Citadel Advisors's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
  • Citadel Advisors added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
  • Citadel Advisors's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
  • Citadel Advisors fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
  • Citadel Advisors's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
  • Citadel Advisors opened 1,989 new positions and closed 1,130 in Q4 2020.
  • Citadel Advisors's portfolio value rose 9.1% quarter-over-quarter to $385B.

Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.